AlphaStocks
4.4
Weak

Globus Medical Inc (GMED)

As of Sep 20, 2026, Globus Medical Inc (GMED) scores 4.4/10 on AlphaStocks' five-model composite, #130 of 168 Health Care stocks. At $74, GMED trades 29% below its model fair value of $105.

Health Care / Health Care Equipment

S&P MidCap 400

$74.11

Below average on several measures. Research carefully.

Weak

Score based on 5 of 5 models — high confidence

Data as of Sep 20, 2026

#130out of 168 in Health Care

Is GLOBUS MEDICAL INC a Good Investment in 2026?

GLOBUS MEDICAL INC (GMED) scores 4.4 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates GLOBUS MEDICAL INC as Strong (9/9). The Greenblatt Magic Formula model is the least favorable, rating it Neutral. GLOBUS MEDICAL INC currently trades 29% below its estimated fair value of $105. GLOBUS MEDICAL INC ranks #130 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E18.9ROE12.0Market Cap10B

Estimated Fair Value

$104.6029% below

Trading below estimated fair value. EPS grew 425% year-over-year. P/E of 19x is moderate for this quality level.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Strong

9/9

Buffett

Attractive

Business quality & competitive moat

Graham

Neutral

44% above fair value

Lynch

Neutral

High PEG — growth premium · Slow Grower

Greenblatt

Neutral

Earnings yield 4.7% · ROC 22%

Frequently Asked Questions

Is GLOBUS MEDICAL INC (GMED) a good investment?
As of Sep 20, 2026, Globus Medical Inc (GMED) scores 4.4/10 on AlphaStocks' five-model composite, #130 of 168 Health Care stocks. At $74, GMED trades 29% below its model fair value of $105. That score is below average, suggesting caution.
What is GLOBUS MEDICAL INC's Piotroski F-Score?
GLOBUS MEDICAL INC's Piotroski F-Score status is Strong. The raw score is 9/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is GMED overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $105, GMED appears undervalued. The stock currently trades 29% below its estimated fair value. Trading below estimated fair value. EPS grew 425% year-over-year. P/E of 19x is moderate for this quality level.
How does GMED compare to other Health Care stocks?
GLOBUS MEDICAL INC ranks #130 out of 168 stocks in the Health Care sector, placing it in the top 77% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about GMED?
AlphaStocks evaluates GMED using five proven investment models. Piotroski: Strong; Buffett: Attractive; Graham: Neutral; Lynch: Neutral; Greenblatt Magic Formula: Neutral. These models are combined into a single composite score of 4.4/10.

Similar Stocks

INSPUFPTBDX

Compare GMED with

GMED vs INSPGMED vs UFPTBDX vs GMED

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer